Hide Board Information

Show Board Information

DB MSCI Emerging Markets Trn Idx ETF XMEM

Board Mod: Add me as mod

Asst Mods:

Last Post: 06/04/2012 2:03:31 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

DB MSCI Emerging Markets Trn Idx ETF (XMEM) Stock Message Board

Find XMEM Recent News, XMEM Filings, XMEM Stock Quote, XMEM Stock Chart, XMEM Research & Opinions Below

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

Be the first to post on DB MSCI Emerging Markets Trn Idx ETF XMEM

Recent Articles

• Leslie's Performance in Q4: Key Insights and Future Prospects
• Exploring Central Garden & Pet's Recent Earnings Performance
• Insights into Enanta Pharma's Q4 Earnings Performance
• Blue Bird's Q4 Earnings Report Reveals Key Insights
• NHTSA Stands Firm on New Emergency Braking Rule for Vehicles
• Columbia Financial Appoints Matthew Smith as New COO
• Impact of Treasury Picks on Markets and Emerging Economies
• Market Reactions: Insights on Zoom, Agilent, HanesBrands, Kohl's
• Zoom Communications Enhances Forecast Following Strong Q3 Results
• Leadership Transition at Kohl's: Kingsbury's Departure Announced
• Tempest Therapeutics to Showcase Innovations at Key Conference
• Travere Therapeutics Announces Key Upcoming Investor Conferences
• Tesla Stock Faces Market Challenges Amid California Proposals
• Chegg Inc. Experience Stock Surge Following Debt Repurchase Deal
• Zoom Communications Turns a Profit with Impressive Q3 Earnings
• First Capital, Inc. Declares New Quarterly Dividend for Investors
• Columbia Financial Welcomes New COO Matthew Smith Amid Changes
• Universal Health Realty Income Trust Boosts Quarterly Dividend
• Amazon Strengthens AI Alliances with Major Investment in Anthropic
• Enanta Pharma's Q4 Earnings Exceed Expectations, Highlights Ahead
• Woodward's Q4 Earnings Highlights and Future Outlook for Investors
• Blue Bird's Q4 Earnings: Performance Review and Insights
• Central Garden & Pet: Analyzing Quarterly Earnings Results
• Central Garden & Pet Q4 Earnings Show Surprising Results
• Semtech's Q3 Earnings Report Shows Promising Growth
• LanzaTech Expands Board for Future Growth with Energy Expert
• Zimmer Biomet Secures FDA Approval for Innovative Knee Implant
• Remitly to Showcase Innovations at Upcoming TMT Summit
• Dana Incorporates Leadership Change Amid Strategic Transformation
• Lexicon Pharmaceuticals Announces Upcoming December Investor Events
• Gaming and Leisure Properties, Inc. Announces Q4 2024 Dividend
• NJR Clean Energy Ventures Finalizes $132.5 Million Solar Sale
• ORIC Pharmaceuticals Enhances Visibility at December Conferences
• LanzaTech Welcomes Thierry Pilenko to Board of Directors
• Ant Group's IPO Collapse: Alibaba's Regulatory Struggles and Settlement Impact
• EMP Metals Secures $3 Million Loan Agreement with Tembo
• Leslies Experiences Financial Challenges in Latest Earnings
• Dana Incorporates Strategic Changes to Boost Growth and Value
• Fluence Energy Delivers Impressive Q4 Results and Growth Insights
• StealthGas Reports Impressive Q3 Earnings Growth
• Analyzing PennantPark Floating Rate's Q4 Earnings Results
• Insights on Pennant Park Investment's Latest Earnings Report
• Central Garden & Pet Reports Improved Q4 Earnings Results
• Enanta Pharma Reports Strong Q4 Earnings Surprising Analysts
• Woodward's Impressive Earnings Surge: Insights and Guidance
• Blue Bird's Q4 Earnings Report: Insights and Analysis
• Overview of New Jersey Resources' Recent Earnings Report
• Central Garden & Pet Surprises Investors with Earnings Report
• Enanta Pharma Reports Promising Q4 Earnings Highlights
• Blue Bird Faces Earnings Challenge: A Detailed Overview